23 results
Pulmonary Infections in HIV-AIDS
Bacterial: 
 • No organism identified, Strep pneumoniae, H. influenzae, S.aureus, Streptococcus Grp
Pulmonary Infections ... in HIV-AIDS Bacterial ... < 200: CMV, HSV ... < 200: Pulmonary ... ID_fellows #Pulmonary
Cytomegalovirus (CMV) in HIV-AIDS Patients
Cytomegalovirus (CMV): double-stranded DNA virus, herpesvirus family.
CMV infection: virus isolation or detection
) in HIV-AIDS Patients ... CMV infection: virus ... patient with HIV and CD4 ... • Endocrine: Infectious ... Pancreatitis • Pulmonary
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Lymphohistiocytosis (HLH) Pathophysiology ... →Activation of CD8 ... that disrupts immune ... +: Virus (EBV, CMV ... or biologics (CMV
Immune Reconstitution Inflammatory Syndrome (IRIS) - Pathophysiology
Risk factors:
 - Low CD4 count
 - Disseminated OI
 -
Syndrome (IRIS) - Pathophysiology ... factors: - Low CD4 ... response to OI (in CM ... duration or OI treatment ... #AIDS
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
Immune Reconstitution ... of HIV/AIDS patients ... be present: • AIDS ... Lymphadenitis, pulmonary ... keratitis, iritis • CMV
Invasive Aspergillus (IA) - Diagnosis and Management
Aspergillus is ubiquitous in nature. Most invasive infections are caused
impaired cellular immune ... , Advanced HIV/AIDS ... presentations: • Pulmonary ... this morphology Treatment ... Diagnosis #Management #treatment
CNS Infection in HIV / AIDS - Differential Diagnosis Framework

Principles of HIV-Associated CNS Opportunistic Infections:
 •
HIV / AIDS - Differential ... Antimicrobial treatment ... required until immune ... - Generally >3 cm ... differential #diagnosis #AIDS
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
Cytomegalovirus Infections ... in HIV-AIDS Preventing ... ART to maintain CD4 ... effective for treatment ... control of the infection
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... Progression: (+) Immune ... rest LTBI (-) Immune ... Tuberculosis Treatment ... Initiating Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... Progression: (+) Immune ... rest LTBI (-) Immune ... Tuberculosis Treatment ... Initiating Treatment